IAM Market moves to the IAM platform
The global marketplace allows IP rights owners to present assets for license, sale or transfer to our unique audience of senior decision takers and deal makers
The global marketplace allows IP rights owners to present assets for license, sale or transfer to our unique audience of senior decision takers and deal makers
“In 2022 we chose to wind down our wireless patent pools. Consistent with that decision, we are also exiting the Alium partnership,” states Via LA President Heath Hoglund
Although heavy reliance on government-backed initiatives creates uncertain future for IP holders
Following the firm’s recent $115 million investment, Sagard Healthcare Royalty Partners’ Ali Alagheband says a flurry of activity is underway in the market
03 October 2022
The Japanese company is leading the pack in trend of commercialising de-prioritised assets
30 September 2022
CEO John Chen tells investors that plans to rebuild the in-house operation are being finalised but says he remains confident a deal with Catapult IP will be done
29 September 2022
Companies in more industries and sectors are looking to raise capital using their intellectual property as collateral
28 September 2022
As long as key issues of concern are always addressed, collective licensing will continue to get regulatory sign-off
27 September 2022
Data from AST shows that wider economic uncertainties had an impact on secondary market activity between April and June with deal numbers falling to under 300
16 September 2022
Patent-backed rare disease innovations secure more M&A/licensing investment than any pharma assets outside oncology
07 September 2022
With the inauguration of the UP regime in 2023 and the effects that it will have on patent transactions and deals, companies should be up to speed on which national law will apply to their granted UPs and whether they would benefit from restructuring their European operations.
31 August 2022
Third Eye Capital syndicate due to provide $400 million for the purchase of the portfolio pulls out, but replacements are said to be on hand
31 August 2022
Innovations in the space are attracting growing attention from investors and Big Pharma
29 August 2022
Unlock unlimited access to all IAM content